glp-1 drugs for type 2 diabetes Can 1 and Type Patients Use Medications Lilly's Oral GLP-1 Foundayo Outperforms

As per clinical trial data, retatrutide is generally safe but causes side effects including nausea, vomiting and diarrhea

As Yaribeygi, Journal of Cellular Physiology emphasized, while mitochondrial peptides hold therapeutic promise, their systemic effects require caution due to the lack of long-term human studies

There is also growing evidence that the use of GLP-1RAs could lead to broader consumer habit changes such as a reduction in calories consumed and an increase in physical activity and changes in overall population health (e.g

The best results seem to come with doses around 2,000 mg per day among overweight and obese individuals, and the effects typically appear over 12 to 24 weeks , with weight loss plateauing after a few months in most studies